UrzÄ™dowy Wykaz 2008 CzÄ™Å›Ä‡ 1 A

More documents

Recommendations

Info

Lp. Nazwa produktu leczniczego Skład 7418 Solcoseryl Sucha masa bezbiałkowego dializatu z krwi cieląt 7419 Solcoseryl Sucha masa bezbiałkowego dializatu z krwi cieląt 7420 Solcoseryl Sucha masa bezbiałkowego dializatu z krwi cieląt 7421 Solcoseryl Sucha masa bezbiałkowego dializatu z krwi cieląt 7422 Solcoseryl Sucha masa bezbiałkowego dializatu z krwi cieląt 7423 Solcoseryl Sucha masa bezbiałkowego dializatu z krwi cieląt 7424 Solcoseryl Sucha masa bezbiałkowego dializatu z krwi cieląt Postać farmaceutyczna Dawka Wielkość opakowania Kat. dost. Podmiot odpowiedzialny Numer pozwolenia Wytwórca maść 2,07 mg/g 1 op. 20 g OTC ICN Polfa Rzeszów S.A. 2071 Solco Basel - Przedsiębiorstwo Zagraniczne maść 2,07 mg/g 1 op. 20 g OTC ICN Polfa Rzeszów S.A. 2876 ICN Polfa Rzeszów S.A. PL pasta do stosowania w jamie ustnej roztwór do wstrzykiwań domięśniowych i dożylnych 7425 Solian Amisulpridum tabletki 50 mg 30 tabl. 90 tabl. Kraj wytwórcy 2,125 mg/g 1 op. 5 g OTC ICN Polfa Rzeszów S.A. 2070 ICN Switzerland AG CH 42,5 mg/ml 25 amp. 2 ml Rp ICN Polfa Rzeszów S.A. 3558 ICN Polfa Rzeszów S.A. Solco Basel - Przedsiębiorstwo Zagraniczne żel 4,15 mg/g 1 op. 20 g OTC ICN Polfa Rzeszów S.A. 2072 Solco Basel - Przedsiębiorstwo Zagraniczne żel 4,15 mg/g 1 op. 20 g OTC ICN Polfa Rzeszów S.A. 2627 ICN Polfa Rzeszów S.A. PL żel do oczu 8,3 mg/g 1 tuba 5 g Rp ICN Polfa Rzeszów S.A. 4130 Solco Basel - Przedsiębiorstwo Zagraniczne Rp Rp Sanofi-Aventis France 8407 Sanofi-Winthrop Industrie F 7426 Solian Amisulpridum tabletki 100 mg 30 tabl. Rp Sanofi-Aventis France 8408 Sanofi-Winthrop Industrie F 7427 Solian Amisulpridum tabletki 200 mg 30 tabl. 90 tabl. Rp Rp Sanofi-Aventis France 8409 Sanofi-Winthrop Industrie F 7428 Solian Amisulpridum tabletki powlekane 400 mg 30 tabl. Rp Sanofi-Aventis France 8410 Sanofi-Winthrop Industrie F 7429 Solnasin 0,65% Natrii chloridum krople do nosa, roztwór 6,5 mg/ml 1 poj. 10 ml OTC Zakłady Farmaceutyczne "POLPHARMA" S.A. Strona 744 z 907 6676 Zakłady Farmaceutyczne "POLPHARMA" S.A. PL PL PL PL PL PL
Lp. Nazwa produktu leczniczego Skład 7430 Solpadeine Paracetamolum + Coffeinum + Codeini phosphas 7431 Solpadeine Codeinum + Coffeinum + Paracetamolum 7432 Solpadeine Paracetamolum + Coffeinum + Codeini phosphas Postać farmaceutyczna kapsułki 500 mg + 30 mg + 8 mg tabletki 8 mg + 30 mg + 500 mg tabletki musujące 500 mg + 30 mg + 8 mg Dawka Wielkość opakowania 12 kaps. 24 kaps. 12 tabl. 24 tabl. 12 tabl. 24 tabl. 7433 Solpaflex Ibuprofenum tabletki powlekane 200 mg 12 tabl. 24 tabl. 7434 Solpaflex Ibuprofenum żel 5 mg/ml 1 tuba 4 g 1 tuba 30 g 1 tuba 50 g 1 tuba 100 g 7435 Solu Medrol Methylprednisolonum proszek i rozp. do sporządzania roztworu do wstrzykiwań 7436 Solu Medrol Methylprednisolonum proszek i rozp. do sporządzania roztworu do wstrzykiwań 7437 Solu Medrol Methylprednisolonum liofilizat i rozp. do sporządzania roztworu do wstrzykiwań domięśniowych i dożylnych 7438 Solu Medrol Methylprednisolonum proszek i rozp. do sporządzania roztworu do wstrzykiwań Kat. dost. OTC Rp OTC Rp OTC Rp OTC OTC OTC OTC OTC OTC Podmiot odpowiedzialny GlaxoSmithKline Consumer Healthcare Sp. z o.o. GlaxoSmithKline Consumer Healthcare Sp. z o.o. GlaxoSmithKline Consumer Healthcare Sp. z o.o. GlaxoSmithKline Consumer Healthcare Sp. z o.o. GlaxoSmithKline Consumer Healthcare Sp. z o.o. 40 mg 1 fiol. proszku + rozp. Rp Pfizer Manufacturing Belgium N.V. 125 mg 1 fiol. proszku + rozp. Rp Pfizer Manufacturing Belgium N.V. 250 mg 1 fiol. liof. + rozp. Rp Pfizer Manufacturing Belgium N.V. 500 mg 1 fiol. proszku + rozp. Rp Pfizer Manufacturing Belgium N.V. Strona 745 z 907 Numer pozwolenia Wytwórca 3436 SmithKline Beecham Lab. Pharmaceutiques Kraj wytwórcy 4999 SmithKline Beecham IRL 3435 SmithKline Beecham IRL 9903 GlaxoSmithKline Dungarvan Ltd. F IRL 9904 Fleet Laboratories Ltd. GB 1553 Pfizer Manufacturing Belgium N.V. 2366 Pfizer Manufacturing Belgium N.V. 3116 Pfizer Manufacturing Belgium N.V. 2367 Pfizer Manufacturing Belgium N.V. B B B B
Page 1 and 2:
Lp. Nazwa produktu leczniczego Skł
Page 3 and 4:
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Lp. Nazwa produktu leczniczego 181
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
Page 345 and 346:
Page 347 and 348:
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 385 and 386:
Page 387 and 388:
Page 389 and 390:
Page 391 and 392:
Page 393 and 394:
Page 395 and 396:
Page 397 and 398:
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427 and 428:
Page 429 and 430:
Page 431 and 432:
Page 433 and 434:
Page 435 and 436:
Page 437 and 438:
Page 439 and 440:
Page 441 and 442:
Page 443 and 444:
Page 445 and 446:
Page 447 and 448:
Page 449 and 450:
Page 451 and 452:
Page 453 and 454:
Page 455 and 456:
Page 457 and 458:
Page 459 and 460:
Page 461 and 462:
Page 463 and 464:
Page 465 and 466:
Page 467 and 468:
Page 469 and 470:
Lp. 4725 Maglek B 6 4726 Magne B 6
Page 471 and 472:
Page 473 and 474:
Page 475 and 476:
Page 477 and 478:
Page 479 and 480:
Page 481 and 482:
Page 483 and 484:
Page 485 and 486:
Page 487 and 488:
Page 489 and 490:
Page 491 and 492:
Page 493 and 494:
Page 495 and 496:
Page 497 and 498:
Page 499 and 500:
Page 501 and 502:
Page 503 and 504:
Page 505 and 506:
Page 507 and 508:
Page 509 and 510:
Page 511 and 512:
Page 513 and 514:
Page 515 and 516:
Page 517 and 518:
Page 519 and 520:
Page 521 and 522:
Page 523 and 524:
Page 525 and 526:
Page 527 and 528:
Page 529 and 530:
Page 531 and 532:
Page 533 and 534:
Page 535 and 536:
Page 537 and 538:
Page 539 and 540:
Page 541 and 542:
Page 543 and 544:
Page 545 and 546:
Page 547 and 548:
Page 549 and 550:
Page 551 and 552:
Page 553 and 554:
Page 555 and 556:
Page 557 and 558:
Page 559 and 560:
Page 561 and 562:
Page 563 and 564:
Page 565 and 566:
Page 567 and 568:
Page 569 and 570:
Page 571 and 572:
Page 573 and 574:
Page 575 and 576:
Page 577 and 578:
Page 579 and 580:
Page 581 and 582:
Page 583 and 584:
Page 585 and 586:
Page 587 and 588:
Page 589 and 590:
Page 591 and 592:
Page 593 and 594:
Page 595 and 596:
Page 597 and 598:
Page 599 and 600:
Page 601 and 602:
Page 603 and 604:
Page 605 and 606:
Page 607 and 608:
Page 609 and 610:
Page 611 and 612:
Page 613 and 614:
Page 615 and 616:
Page 617 and 618:
Page 619 and 620:
Page 621 and 622:
Page 623 and 624:
Page 625 and 626:
Page 627 and 628:
Page 629 and 630:
Page 631 and 632:
Page 633 and 634:
Page 635 and 636:
Page 637 and 638:
Page 639 and 640:
Page 641 and 642:
Page 643 and 644:
Page 645 and 646:
Page 647 and 648:
Page 649 and 650:
Page 651 and 652:
Page 653 and 654:
Page 655 and 656:
Page 657 and 658:
Page 659 and 660:
Page 661 and 662:
Page 663 and 664:
Page 665 and 666:
Page 667 and 668:
Page 669 and 670:
Page 671 and 672:
Page 673 and 674:
Page 675 and 676:
Page 677 and 678:
Page 679 and 680:
Page 681 and 682:
Page 683 and 684:
Page 685 and 686:
Page 687 and 688:
Page 689 and 690:
Page 691 and 692:
Page 693 and 694: Lp. Nazwa produktu leczniczego Skł
Page 703 and 704: Lp. Nazwa produktu leczniczego 7003
Page 743: Lp. Nazwa produktu leczniczego Skł
Page 795 and 796:
Page 797 and 798:
Page 799 and 800:
Page 801 and 802:
Page 803 and 804:
Page 805 and 806:
Page 807 and 808:
Page 809 and 810:
Page 811 and 812:
Page 813 and 814:
Page 815 and 816:
Page 817 and 818:
Page 819 and 820:
Page 821 and 822:
Page 823 and 824:
Page 825 and 826:
Page 827 and 828:
Page 829 and 830:
Page 831 and 832:
Page 833 and 834:
Page 835 and 836:
Page 837 and 838:
Page 839 and 840:
Page 841 and 842:
Page 843 and 844:
Page 845 and 846:
Page 847 and 848:
Page 849 and 850:
Page 851 and 852:
Page 853 and 854:
Page 855 and 856:
Page 857 and 858:
Page 859 and 860:
Page 861 and 862:
Page 863 and 864:
Page 865 and 866:
Page 867 and 868:
Page 869 and 870:
Page 871 and 872:
Page 873 and 874:
Page 875 and 876:
Page 877 and 878:
Page 879 and 880:
Page 881 and 882:
Page 883 and 884:
Page 885 and 886:
Page 887 and 888:
Page 889 and 890:
Page 891 and 892:
Page 893 and 894:
Page 895 and 896:
Page 897 and 898:
Page 899 and 900:
Page 901 and 902:
Page 903 and 904:
Page 905 and 906:
Page 907:
show all

UrzÄ™dowy Wykaz 2008 CzÄ™Å›Ä‡ 1 A

Create successful ePaper yourself

Delete template?

Save as template?